LINC00346 regulates glycolysis by modulation of glucose transporter 1 in breast cancer cells

Yaxun Li,Hao Li,Wei Wang,Xiaodong Yu,Qun Xu
DOI: https://doi.org/10.1016/j.mcp.2020.101667
IF: 3.285
2020-12-01
Molecular and Cellular Probes
Abstract:<p>Most cancer cells preferentially metabolize glucose by glycolysis rather than oxidative phosphorylation to proliferate efficiently. LncRNAs have been proposed as crucial regulators in pathophysiological processes including cell growth, apoptosis and glucose metabolism. However, little is known regarding the specific role of LINC00346 in regulating glucose metabolism in breast cancer. LINC00346 and miR-148a/b expression in breast cancer cells was detected by qRT-PCR. The relationships between LINC00346, glucose transporter 1 (GLUT1) and miR-148a/b in breast cancer cells were explored by luciferase reporter assay. Cell proliferation and apoptosis were evaluated by CCK-8 and flow cytometry analysis, respectively. Glycolysis was detected by measuring the glucose uptake and lactate production. Results showed that LINC00346 was over-expressed while miR-148a/b was low-expressed in breast cancer cells. miR-148a/b were direct targets of LINC00346 in breast cancer cells. LINC00346 knockdown inhibited cell proliferation and glycolysis, and induced apoptosis by upregulating miR-148a/b in breast cancer cells. Furthermore, we found that LINC00346 knockdown repressed GLUT1 expression in breast cancer cells by upregulating miR-148a/b. In conclusion, LINC00346 knockdown suppressed breast cancer cell glycolysis by upregulating miR-148a/b and repressing GLUT1 expression.</p>
cell biology,biochemistry & molecular biology,biochemical research methods,biotechnology & applied microbiology
What problem does this paper attempt to address?
This paper aims to explore the specific role of long - non - coding RNA LINC00346 in breast cancer cells and its regulatory mechanism. Specifically, the study focuses on how LINC00346 affects the glycolysis process of breast cancer cells by regulating glucose transporter 1 (GLUT1). The study found that LINC00346 is over - expressed in breast cancer cells, while miR - 148a/b is low - expressed. Further research shows that LINC00346 can inhibit the expression of miR - 148a/b by acting as a molecular sponge of miR - 148a/b, thereby up - regulating the expression of GLUT1, promoting the proliferation and glycolysis of breast cancer cells, and inhibiting apoptosis. Therefore, the main problem of this study is to explore the role of LINC00346 in the glycolysis process of breast cancer cells and its specific regulatory mechanism through miR - 148a/b and GLUT1. ### Main findings: 1. **Differences in the expression of LINC00346 and miR - 148a/b**: - LINC00346 is over - expressed in breast cancer cells, while miR - 148a/b is low - expressed. - LINC00346 is mainly located in the cytoplasm. 2. **Interaction between LINC00346 and miR - 148a/b**: - Bioinformatics analysis predicts that miR - 148a/b may be the target of LINC00346. - Dual - luciferase reporter gene experiments verified that LINC00346 can act as a molecular sponge of miR - 148a/b. 3. **Effects of LINC00346 knockdown on cell proliferation and apoptosis**: - LINC00346 knockdown inhibits the proliferation of breast cancer cells and induces apoptosis. - Inhibiting miR - 148a/b can partially reverse the effects of LINC00346 knockdown on cell proliferation and apoptosis. 4. **Effects of LINC00346 knockdown on glycolysis**: - LINC00346 knockdown reduces glucose uptake and lactate production in breast cancer cells and inhibits glycolysis. - Inhibiting miR - 148a/b can partially reverse the effects of LINC00346 knockdown on glycolysis. 5. **Effects of LINC00346 knockdown on GLUT1 expression**: - GLUT1 is predicted to be the target of miR - 148a/b. - Dual - luciferase reporter gene experiments verified that miR - 148a/b can inhibit the expression of GLUT1. - LINC00346 knockdown inhibits the expression of GLUT1 by up - regulating miR - 148a/b. ### Conclusion: In breast cancer cells, LINC00346 inhibits the expression of miR - 148a/b by acting as a molecular sponge of miR - 148a/b, and then up - regulates the expression of GLUT1, promotes cell proliferation and glycolysis, and inhibits apoptosis. These findings reveal the important role of LINC00346 in breast cancer progression and provide new insights for its potential as a therapeutic target.